Moderna (MRNA) Stock Price Today, Real-Time Quotes, Forecasts

Moderna (MRNA) Stock: Real Time Chart and Quotes

Moderna (MRNA) Stock
Moderna
MRNA
Stock = Moderna, Inc.
ISIN = US0231351067
About company = Moderna Inc. is a US biotech company. Develops drugs and vaccines. Based in Cambridge (Massachusetts). He is engaged in the development of innovative drugs based on matrix ribonucleic acid (mRNA).

Forecasts, Upside Potential for Moderna (MRNA) stock in the Next 12 Months

Stock Consensus Rating = "Neutral"
Lowest Price Target
$70
Average target price
$178
Maximum target price
$221

Moderna (MRNA) Stock Forecasts and Target Prices for 2023

On June 7, 2022, analysts at SVB Leerink released the latest price target for Moderna (NASDAQ: MRNA) stock at $70 over the next 12 months. Over the past year, 28 analyst firms have published forecasts for Moderna (NASDAQ: MRNA) stock for 2023. The general consensus-forecast of analysts is “neutral”. Analysts’ average price target is set at $178 over the next 12 months. Analysts’ latest target prices can be found in the table below.

Forecast dateAnalytical firm Change target price Rating
06/07/2022 SVB Leerink
$80→$70
Underperform
05/18/2022 Piper Sandler
$348→$214
Overweight
05/05/2022 Morgan Stanley
$217→$199
Equal-Weight
03/07/2022 Deutsche Bank
$175→$155
Hold
01/21/2022 UBS →$221→ Neutral
01/21/2022 B of A Securities
$135→$180
Underperform → Neutral

Alex Belov

Developers by oneinveststock.com. Analyst, investor